Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon acquired 27 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were bought at an average cost of GBX 1,445 ($18.66) per share, with a total value of £390.15 ($503.81).
Liam Condon also recently made the following trade(s):
- On Wednesday, January 22nd, Liam Condon purchased 30 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,362 ($17.59) per share, for a total transaction of £408.60 ($527.63).
Johnson Matthey Stock Up 1.0 %
LON:JMAT traded up GBX 14 ($0.18) during trading hours on Monday, reaching GBX 1,401 ($18.09). The company's stock had a trading volume of 832,101 shares, compared to its average volume of 2,846,151. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The company has a market capitalization of £2.34 billion, a P/E ratio of 23.81, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The stock has a 50 day moving average price of GBX 1,423.24 and a two-hundred day moving average price of GBX 1,456.17. Johnson Matthey PLC has a 12 month low of GBX 1,295.54 ($16.73) and a 12 month high of GBX 1,917.07 ($24.76).
Wall Street Analyst Weigh In
A number of research firms recently weighed in on JMAT. Berenberg Bank cut their target price on shares of Johnson Matthey from GBX 1,650 ($21.31) to GBX 1,500 ($19.37) and set a "hold" rating for the company in a report on Thursday, November 28th. Jefferies Financial Group reiterated a "buy" rating and set a GBX 1,800 ($23.24) price objective on shares of Johnson Matthey in a report on Tuesday, December 17th.
Check Out Our Latest Analysis on Johnson Matthey
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
